Football

Jalen Hurts’ Blood Clot Raises Questions About NFL Team Medical Care

Oct 19, 2026 • 5 min read • views

The central question in the Jalen Hurts blood clot case isn’t whether he could play. It’s whether the medical decisions around him put his health first. Public details remain incomplete, but the Eagles’ account has left enough uncertainty to renew a larger concern about how NFL teams define the role of their doctors. That concern reaches beyond one player or one diagnosis: team physicians work in settings where care and competition are closely tied, even when those goals point in different directions.

At a Monday news conference, coach Nick Sirianni said the doctors and trainers involved were the same staff who helped “21 of our 22 starters be available in the Super Bowl,” adding that they “deeply care about our guys.” The expression may have been incidental. Still, it points to a tension built into team medicine: a player wants to compete, a team wants its best players on the field, and the medical staff is employed by that team. Availability is a familiar measure of a team’s success, but it’s a poor substitute for explaining how a difficult medical decision was reached.

Availability and patient care

Doctors should treat players as patients first. When a health problem arises, the aim should be to provide appropriate care, even if that means a player can’t take part. If the doctor’s practical mandate becomes getting the player ready, the standard can slide from “What’s safest for this person?” to “What would let him play?” That shift doesn’t require anyone to act in bad faith; incentives and expectations can shape decisions even when everyone involved believes they’re acting in the player’s interest.

That tension helps explain why the NFL introduced unaffiliated physicians into concussion evaluations after Congress pressed the league to take head injuries seriously. Independent medical input can help protect a decision from the competing interests surrounding a game. It also gives players and the public a clearer basis for understanding who assessed the injury and whether the evaluation was insulated from the push to return. The Hurts situation raises the question of whether similar scrutiny is needed for other serious conditions, where the medical risks and the appropriate safeguards may differ.

It’s not enough to say that team doctors care about their players. The issue is whether the structure gives them room to make a health-first call when that call conflicts with a player’s or team’s desire to play. A physician who repeatedly rules players out may face pressure, spoken or not, that a physician who clears them does not. That pressure can be subtle: a team’s schedule, a player’s own urgency, and the expectation of availability all sit in the background of the clinical decision.

The public record has added to the concern. Early accounts suggested Hurts had been advised not to sleep after a blood clot was found in his leg. Tom Pelissero later revised his report, first saying Hurts had been told not to sleep and didn’t, then reporting that Hurts slept at least a little at the stadium. Those accounts leave basic questions unresolved rather than clarifying the medical reasoning. They don’t establish what advice was given, who gave it, or how the evolving information affected the plan. The uncertainty is itself part of the story: a public explanation should distinguish confirmed medical facts from reports that changed over time.

The unanswered travel question

Another unresolved issue is why Hurts flew across the Atlantic after the clot had been diagnosed, less than three days after making the same journey with an undiagnosed clot. The available information doesn’t establish what the doctors considered or what risks they discussed. That gap matters: the decision should be understood in terms of the patient’s health, not just the possibility that he might play against the Panthers. Travel after a diagnosis is a medical question with context that outsiders don’t have, which makes a careful account of the reasoning more useful than speculation about the answer.

The immediate response to a blood clot should center on evaluating and managing the condition. Instead, the sequence of events has left the impression that the practical question was how to keep Hurts available. That impression may be incomplete, but the team’s limited explanation has done little to dispel it. Here’s the thing: when a team shares only fragments, people fill the gaps with the most visible motive—the game. A fuller account of the process could help clarify whether that impression is fair.

Hurts avoided the worst outcome, including a pulmonary embolism. That doesn’t make the decisions around his care unimportant. A favorable outcome can’t, by itself, show whether the process was sound; medical decisions have to be judged by what was known and considered at the time. This is more significant than it looks: the question is whether a system built around competition can show that a player’s health remains the first priority when the stakes are immediate.

What the case should prompt

The league and its teams should use this case to examine how medical judgments are made, who is involved, and whether independent review is appropriate when a player’s health and availability pull in different directions. That review would need to account for the specifics of the condition rather than assume every diagnosis calls for the same process. (And this is the part most people overlook.) Independence matters only if the person providing it has enough information and authority to affect the decision.

If you’re working in this space, the practical test is whether a physician can recommend rest, further evaluation, or a player’s absence without the team’s competitive needs quietly setting the terms. The right first question for team doctors is simple: what care does this player need? Whether he can return to the field should follow from that answer, not set it.

That principle is easy to state and harder to demonstrate. Clearer explanations of the decision process would help players, teams, and the public understand where medical judgment ends and competitive pressure begins. No easy answers.